No Data
No Data
Guangdong VTR Bio-Tech (stock code: 300381.SZ): As of May 20th, the number of shareholders in the company was 31,029.
Guangdong VTR Bio-tech (300381.SZ) stated on its investor platform that as of May 20th, 2024, the number of shareholders in the company was 31,029.
Guangdong VTR Bio-Tech (300381.SZ) plans to distribute RMB 0.6 per 10 shares for 2023 with ex-right and ex-dividend on June 18.
Guangdong VTR Bio-Tech (300381.SZ) announced that the equity distribution plan for the year 2023 is to distribute a dividend of ¥1.00 (tax included) to all shareholders for every 10 shares held.
Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) Not Doing Enough For Some Investors As Its Shares Slump 26%
The Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) share price has softened a substantial 26% over the previous 30 days, handing back much of the gains the stock has made lately. The drop over the
Etrix (300381.SZ) plans to acquire the remaining 49% of German VE shares to advance the implementation of overseas market expansion strategies
Etrix (300381.SZ) announced that the company holds Victory Awards G...
Edriol (300381.SZ): In terms of biosynthetic products, 5-aminoacetylpropionic acid has now basically reached the level of industrialization
Gelonghui, May 9, 丨 Yiduoli (300381.SZ) said on the investor interactive platform that the company is focusing on three types of business: biological enzyme preparations, biosynthetics, and nutritional and health products. In terms of biosynthetics, 5-aminoacetylpropionic acid has now basically reached the level of industrialization, but it has not yet formed a product to be introduced to the market. Investors are invited to invest rationally and pay attention to risks.
The top-level file will be released soon! The concept of synthetic biology has risen to prominence, and the pace of industrial development has accelerated
Trillion racetrack
No Data